🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Targeted Lens Intervention for Myopic Anisometropia in Children

RecruitingNAAges 6 Years - 13 YearsAllEssilor International
NCT07533149 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if our research spectacles will lower the difference in prescription (spectacles degree) between the eyes in children between 6 to 13 years old with anisometropic myopia. Anisometropic myopia is when the difference in myopia prescription between the two eyes are more than 1 diopter. The main question it aims to answer is: * How the eye responds to the research spectacles over time by measuring: 1. Change in axial length: the physical length of the eye from front to back. 2. Change in cycloplegic spherical equivalent refraction: an accurate measurement of the eye's prescription taken while the focusing muscles are temporarily relaxed with eye drops. Participants will: * Wear the study spectacles * Visit Essilor R\&D Centre and an eye clinic for follow-up sessions

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Voluntary 2. Informed consent of parent/guardian and assent of participant 3. Age equal to or greater than 6 years old and less than 13 years at the time of signing informed consent and assent 4. SER equal or less than -0.50 D and equal or greater than .5.00 D with astigmatism not more than 2.50 D 5. Difference in SER (anisometropia) between two eyes .1.00 D 6. Best corrected visual acuity (BCVA) better than or equal to +0.20 LogMAR in each eye 7. Agree to wear study spectacles for .12 hours/day and 7 days/week 8. Willingness and ability to participate in investigation for 12 months and attend scheduled visits punctually 9. Agree for no concurrent involvement in other myopia control treatment Exclusion Criteria: 1. History or presence of an ocular disease affecting refractive status 2. History or presence of strabismus 3. Presence of amblyopia 4. Current or previous use of atropine and/or orthokeratology 5. Known allergy to cycloplegic agents 6. Contraindication to cycloplegic agents 7. Cognitive or psychological vulnerability
💊

What it tests

  • More myopic eye: MCL1; Less myopic eye: MCL2
📍

Where

1 site
Essilor R&D Centre Singapore
Singapore, Singapore
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy